Report post
Neuralink, founded by Elon Musk, has announced that it has received approval from the US Food and Drug Administration (FDA) to conduct studies on brain implants in humans. This approval allows Neuralink to proceed with implanting its brain chips in a second patient. The FDA's green light signifies a significant milestone for the neurotech company, paving the way for human trials of Musk's ambitious brain chip project.

The World's Leading Crypto Trading Platform

Get my welcome gifts